ASX Share rice
Wed 12 Aug 2020 - 11:15:am (Sydney)

VBS Share Price

VECTUS BIOSYSTEMS LIMITEDVBSPharmaceuticals, Biotechnology & Life Sciences

VBS Company Information

Name:

Vectus Biosystems Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

3-11 Primrose Avenue Rosebery NSW Australia 2018

Phone:

61 2 9662 4144

CEO & Exec. Director:

Dr. Karen Annette Duggan

Consultant:

Prof. Graham Jon MacDonald AM, M.D., BSc (Med), BS, FRACP, FRCP, FANZCC

Company Sec.:

Mr. Robert John Waring BEc, CA, FCIS, FFin, FAICD

Company Overview:

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. Vectus Biosystems Limited was founded in 2005 and is based in Rosebery, Australia.

VBS Share Price Information

Shares Issued:

23.65M

Market Capitalisation:

$18.69M

Revenue (TTM):

$346

Earnings per Share:

$-0.068

Operating Margin (TTM):

$-6,522.53

Return On Assets (TTM):

$-0.50

Quarterly Revenue Growth (YOY):

1.37

Gross Profit(TTM):

$220

Diluted Earnings Per Share (TTM):

$-0.091

VBS CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$135.36K

Net Borrowings:

$1.04M

Net Income:

$-1,596,280

Total Cash From Operating Activities:

$-1,040,614

Depreciation:

$22.63K

Capital Expenditures:

$0

VBS Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,496,222

Net Income:

$-1,596,280

Gross Profit:

$220

Operating Income:

$-2,373,277

Interest Expense:

$123.17K

Income Tax Expense:

$-899,942

Total Revenue:

$220

Total Operating Expenses:

$2.37M

Cost Of Revenue:

$712K

VBS Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$3.92M

Total Stockholder Equity:

$-3,729,821

Other Current Liabilities:

$523.19K

Total Assets:

$194.11K

Common Stock:

$17.60M

Other Current Assets:

$31.54K

Retained Earnings:

$-21,846,851

Other Liabilities:

$5K

Cash:

$43.17K

Total Current Liabilities:

$1.96M

Property - Plant & Equipment:

$35.13K

Net Tangible Assets:

$-3,729,821

Total Current Assets:

$158.98K

Long-Term Debt:

$1.96M

Net Receivables:

$31.54K

Short-Term Investments:

$35.13K

Accounts Payable:

$1.12M

Non Currrent Assets (Other):

$35.13K

Short-Term Investments:

$35.13

Non Current Liabilities Total:

$1.96M

VBS Share Price History

VBS News

23 Mar, 2020
The CEO of Vectus Biosystems Limited (ASX:VBS) is Karen Duggan. This analysis aims first to contrast CEO compensation...
27 Aug, 2019
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...